Visgeneer Inc. (4197.TWO)
TWD 10.0
(1.01%)
TWD 10.0
(1.01%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 397.17 Million TWD | -18.4% |
| 2022 | 486.73 Million TWD | 13.98% |
| 2021 | 427.04 Million TWD | -7.56% |
| 2020 | 461.96 Million TWD | -3.91% |
| 2019 | 480.76 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 371.71 Million TWD | -6.41% |
| 2024 Q2 | 371.71 Million TWD | 0.0% |
| 2023 FY | 397.17 Million TWD | -18.4% |
| 2023 Q2 | 417.24 Million TWD | 0.0% |
| 2023 Q1 | 417.24 Million TWD | -14.28% |
| 2023 Q3 | 397.17 Million TWD | -4.81% |
| 2023 Q4 | 397.17 Million TWD | 0.0% |
| 2022 Q3 | 486.73 Million TWD | 0.0% |
| 2022 Q4 | 486.73 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 86.308% |
| Level Biotechnology Inc. | 822.67 Million TWD | 51.721% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 40.249% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | 27.621% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 89.8% |
| GlycoNex Incorporation | 1.55 Billion TWD | 74.422% |
| VBI | 452.1 Million TWD | 12.149% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 66.231% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 46.942% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 89.466% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 81.604% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 55.025% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 93.481% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -439.949% |
| Enimmune corporation | 604.82 Million TWD | 34.332% |
| TaiRx, Inc. | 833.74 Million TWD | 52.362% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 87.13% |
| EirGenix Inc. | 11.16 Billion TWD | 96.442% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 30.702% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 76.805% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 88.957% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 62.191% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -31.938% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -50.072% |
| Lukas Biomedical Inc. | 441.19 Million TWD | 9.976% |
| RBC Bioscience Corporation | 753.79 Million TWD | 47.309% |
| BiOptic Inc. | 613.77 Million TWD | 35.289% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 77.67% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 65.752% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 38.408% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 87.214% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -210.18% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -4.972% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 64.971% |
| Neith Corporation | 192.15 Million TWD | -106.698% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -168.482% |
| NaviFUS Corp. | 490.53 Million TWD | 19.032% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 67.596% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 70.868% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | 24.94% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 65.802% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 76.02% |
| AP Biosciences Inc | 890.75 Million TWD | 55.411% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 95.342% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -22.529% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 70.219% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 85.35% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 97.415% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | 3.189% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -0.082% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 80.867% |
| TCI GENE Inc. | 1.16 Billion TWD | 65.935% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -34.827% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 70.867% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 57.826% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 43.135% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 89.955% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 89.61% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 67.705% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 92.912% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 62.601% |
| Acepodia, Inc. | 6.81 Billion TWD | 94.175% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 89.62% |